Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$75.8M
-4.5% from 2023
Prescriptions
6,847
$11,073.19 per claim
Patients
849
683 prescribers
Total spending, 2024
$75.8M
$89,231.88 per patient
Medicare prescription drug plans paid $75.8M for Mayzent in 2024, for 6,847 prescriptions and refills to 849 patients (down 4.5% from 2023). The average cost per claim was $11,073.19.
New York had the highest Medicare cost for Mayzent in 2024: $6.0M for 549 claims, followed by California ($5.3M).
Christopher C Laganke, neurology in Cullman, AL, had the highest Medicare cost for Mayzent in 2024: 137 claims costing $1.4M.
Mayzent is made by Novartis AG (NVS), listed in the Medicare spending data as Novartis.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Christopher C Laganke Cullman, AL | Neurology | 137 | 12 | $1.4M |
| Dana J Beenstock Freehold, NJ | Nurse Practitioner | 80 | 15 | $935K |
| Geeta A Ganesh |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 699 | 7,161 | 949 | $71.3M |
| 2023 | 699 | 7,162 | 927 | $79.4M |
| 2024 | 683 | 6,847 | 849 | $75.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Neurology |
| 78 |
| Under 11 |
| $929K |
| Barry Singer Saint Louis, MO | Neurology | 67 | Under 11 | $843K |
| Rebecca S Romero San Antonio, TX | Neurology | 70 | Under 11 | $818K |
| Jasmin Patel Freehold, NJ | Neurology | 55 | 15 | $749K |
| Randall G Trudell Knoxville, TN | Neurology | 85 | 12 | $741K |
| Khurram Bashir Birmingham, AL | Neurology | 79 | Under 11 | $689K |
| Caren G Marks Freehold, NJ | Neurology | 36 | Under 11 | $680K |
| Erik Burton Shreveport, LA | Neurology | 62 | Under 11 | $585K |
| Ted L Rothstein Washington, DC | Neurology | 61 | Under 11 | $582K |
| Neil S Lava Atlanta, GA | Neurology | 62 | Under 11 | $553K |
| Gabriel Pardo Oklahoma City, OK | Neurology | 44 | Under 11 | $494K |
| Allen D Pettee Rochester, NY | Neurology | 46 | Under 11 | $475K |
| Amos Katz Eatontown, NJ | Neurology | 44 | Under 11 | $471K |
| Thomas J Kwiatkowski Jr. Pittsfield, MA | Neurology | 50 | Under 11 | $457K |
| Bruce A Cree San Francisco, CA | Neurology | 22 | Under 11 | $447K |
| Diana L Vargas Vives Atlanta, GA | Neurology | 37 | Under 11 | $441K |
| Michelle L Apperson Sacramento, CA | Neurology | 23 | Under 11 | $434K |
| Frank S Benesh Birmingham, AL | Neurology | 44 | Under 11 | $418K |
| Joshua J Chalkley Lexington, KY | Neurology | 45 | Under 11 | $418K |
| William Meador Birmingham, AL | Neurology | 44 | Under 11 | $397K |
| Rachel Hanson Bethlehem, PA | Physician Assistant | 35 | Under 11 | $386K |
| Otakar Krcal Kingsport, TN | Neurology | 33 | Under 11 | $367K |
| Christopher A Severson Boston, MA | Neurology | 36 | Under 11 | $364K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis NVS | 6,850 | $75.8M |